Late-effects of Chemoradiotherapy on Growth and Puberty in Survivors of Childhood Acute Lymphoblastic Leukemia

被引:0
|
作者
Eltan, Sevgi Bilgic [1 ]
Akcay, Arzu [2 ]
Bayramoglu, Elvan [3 ]
Eltan, Mehmet [4 ]
Akcay, Teoman [5 ]
Salcioglu, Zafer [5 ]
Aydogan, Gonul [6 ]
机构
[1] Marmara Univ, Dept Pediat Allergy & Immunol, Fac Med, Istanbul, Turkiye
[2] Acibadem Mehmet Ali Aydinlar Univ, Altunizade Hosp, Fac Med, Clin Pediat Hematol & Oncol, Istanbul, Turkiye
[3] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Pediat Endocrinol, Istanbul, Turkiye
[4] Univ Hlth Sci Turkiye, Istanbul Sancaktepe Sehit Prof Dr Ilhan Varank Tra, Clin Pediat Endocrinol, I?stanbul, Turkiye
[5] Uskudar Univ, Sisli Mem Hosp, Clin Pediat, Fac Med, I?stanbul, Turkiye
[6] Univ Hlth Sci Turkiye, Istanbul Kanuni Sultan Suleyman Training & Res Hos, Clin Pediat Hematol & Oncol, I?stanbul, Turkiye
来源
TRENDS IN PEDIATRICS | 2022年 / 3卷 / 04期
关键词
Acute lymphoblastic leukemia; growth; late effects; puberty; obesity; BODY-MASS-INDEX; CRANIAL IRRADIATION; BINDING PROTEIN-3; REFERENCE VALUES; ADULT SURVIVORS; SHORT STATURE; CHILDREN; HEIGHT; CHEMOTHERAPY; PATTERNS;
D O I
10.4274/TP.2022.43043
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: The survival rate of childhood leukemia has reached 80% with evolving treatment modalities over the last 30 years, which is followed by an increased incidence of treatment -related long-term side effects. This study, it was aimed to evaluate the endocrine late effects of chemoradiotherapy in childhood acute lymphoblastic leukemia (ALL). Methods: Forty-eight patients with ALL treated at the University of Health Sciences T & uuml;rkiye, & Idot;stanbul Kanuni Sultan S & uuml;leyman Training and Research Hospital, Clinic of Pediatric Hematology and Oncology between 1997 and 2007 with at least 5 -year follow-up after the chemotherapy, were included. Results: Endocrine side effects were detected in 48% (n=23) of the cases. The most common endocrine side effect was short stature in the group treated with cranial radiotherapy (CRT), and obesity in the group that did not receive CRT. The median height standard deviation score (SDS) of the subjects who reached the final height (FH) was significantly lower [-1.44 (-2.1)-(-0.53)] compared with the median height SDS of the subjects who did not reach the FH [-0.24 (-1.23)-(0.6)]. There was a positive correlation between height SDS and IGF1 SDS, IGFBP3 SDS, body mass index SDS, and advanced bone age in subjects who did not reach FH (r=0.511, p=0.018, r=0.530, p=0.014, r=0.499, p=0.021, r=0.599, p=0.08, respectively). Precocious puberty was found in one patient who received CRT, and hypergonadotropic hypogonadism was found in one patient who did not receive CRT. Twenty-three percent of the group received CRT and 35% of the group who did not receive CRT had overweight/obesity. Central hypothyroidism was detected in one case and subclinical hypothyroidism was detected in two cases. Conclusion: Long-term endocrine side effects were observed in approximately half of the cases with childhood ALL. Children treated with chemoradiotherapy should have endocrine evaluation and from the until the is
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [1] Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia
    Elitzur, Sarah
    Houri-Shtrecher, Revital
    Yackobovitz-Gavan, Michal
    Avrahami, Galia
    Barzilai, Shlomit
    Gilad, Gil
    Lebenthal, Yael
    Phillip, Moshe
    Stark, Batia
    Yaniv, Isaac
    Shalitin, Shlomit
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2017, 30 (08) : 869 - 877
  • [2] Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors
    Kizilocak, Hande
    Okcu, Fatih
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (01) : 1 - 11
  • [3] Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
    Kwiecinska, Kinga
    Strojny, Wojciech
    Pietrys, Danuta
    Bik-Multanowski, Miroslaw
    Siedlar, Maciej
    Balwierz, Walentyna
    Skoczen, Szymon
    ITALIAN JOURNAL OF PEDIATRICS, 2018, 44
  • [4] Endocrinological and Cardiological Late Effects Among Survivors of Childhood Acute Lymphoblastic Leukemia
    Karakaya, Pakize
    Yilmaz, Sebnem
    Tufekci, Ozlem
    Kir, Mustafa
    Bober, Ece
    Irken, Gulersu
    Oren, Hale
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (03) : 290 - 299
  • [5] Physical Activity and Late Effects in Childhood Acute Lymphoblastic Leukemia Long-Term Survivors
    Bertorello, N.
    Manicone, R.
    Galletto, C.
    Barisone, E.
    Fagioli, F.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (05) : 354 - 363
  • [6] Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group
    Pakakasama, Samart
    Veerakul, Gavivann
    Sosothikul, Darin
    Chainansamit, Su-on
    Laosombat, Vichai
    Thanarattanakorn, Pattra
    Lumkul, Rachata
    Wiangnon, Surapon
    Wangruangsathit, Somporn
    Narkbunnam, Nattee
    Kanjanapongkul, Somjai
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (05) : 850 - 854
  • [7] The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors
    Marcoux, Sophie
    Drouin, Simon
    Laverdiere, Caroline
    Alos, Nathalie
    Andelfinger, Gregor U.
    Bertout, Laurence
    Curnier, Daniel
    Friedrich, Matthias G.
    Kritikou, Ekaterini A.
    Lefebvre, Genevieve
    Levy, Emile
    Lippe, Sarah
    Marcil, Valerie
    Raboisson, Marie-Josee
    Rauch, Frank
    Robaey, Philippe
    Samoilenko, Mariia
    Seguin, Chantal
    Sultan, Serge
    Krajinovic, Maja
    Sinnett, Daniel
    PEDIATRIC BLOOD & CANCER, 2017, 64 (06)
  • [8] The metabolic syndrome in survivors of childhood acute lymphoblastic leukemia in Isfahan, Iran
    Reisi, Nahid
    Azhir, Afshin
    Hashemipour, Mahin
    Raeissi, Pouran
    Amini, Abasgholi
    Moafi, Alireza
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2009, 14 (02): : 111 - 116
  • [9] Late Effects in Long-Term Survivors After Treatment for Childhood Acute Leukemia
    Haddy, Theresa B.
    Mosher, Revonda B.
    Reaman, Gregory H.
    CLINICAL PEDIATRICS, 2009, 48 (06) : 601 - 608
  • [10] Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
    Kinga Kwiecinska
    Wojciech Strojny
    Danuta Pietrys
    Miroslaw Bik-Multanowski
    Maciej Siedlar
    Walentyna Balwierz
    Szymon Skoczen
    Italian Journal of Pediatrics, 44